This area is covered by UK Department of Health.
Sexual health charities have put together a Just Say Non campaign website here: www.justsaynon.org.uk/
Relates to this:
www.bpas.org/about-our-charity/press-office/press-releases/emergency-contraception-needs-urgent-review/
(the whole thing on this link is absolutely eye opening but I pasted some of it below)
Emergency Contraception needs urgent review
29 November 2016
Emergency contraception must be reclassified and made available to buy straight from the shop shelf, bpas urges
Women in the UK pay up to £30 for the most basic form of emergency contraception (EC), up to 5 times more than in other European countries
One reason for the high price is the mandatory yet unnecessary and embarrassing consultation women must endure before being sold EC, which is kept firmly behind the counter
As sexual health services providing free EC face cuts, more women will have no choice but to purchase EC to avoid unplanned pregnancy
The British Pregnancy Advisory Service (bpas) believes EC should be reclassified as a General Sales List drug to enable it to be sold straight off the shelf without consultation, at a price women can afford
#justsaynon campaign launched today highlights the outrageously high price of EC in the UK compared to France and calls on women to reject what is the ultimate sexist surcharge
It is now 15 years since the progestogen-only emergency contraceptive Levonelle One Step (now also sold as Boots Emergency Contraceptive and Consilient) was first made available to women to buy from behind the counter in pharmacies after a consultation with a pharmacist. The price was deliberately inflated and a mandatory consultation introduced, apparently to prevent women from using it as a regular method of contraception. Since its introduction, the use of EC in the UK has barely changed and remains low,[1] despite the fact that most women rely on user-dependent methods such as condoms and daily pills and should feel able to use EC when these methods fail or are forgotten.
Research has found that around one third of British women have had unprotected sex in the last 12 months, and the majority (67%) did not use EC.[2] bpas regularly sees women experiencing unplanned pregnancy who were deterred from seeking EC because of the obstacles to access, including the price. bpas is calling for EC to be reclassified as a General Sales List medication so it can be placed on pharmacy selves for women to buy without consultation.